MedWatch

Following recalls and delays, Novo Nordisk kicks off smart insulin pen launch

After two years' delay, Novo Nordisk launches two smart reusable insulin pens. The launch kicks off in Sweden, but will roll out in more countries before long.

Photo: Stine Tidsvilde

After a two year delay, Novo Nordisk has started launching the company's smart reusable insulin pens Novopen 6 and Novopen Echo Plus.

The first launch will revolve around Sweden, but will soon be expanded to Western Europe and many other countries in due course, Novo Nordisk Corporate Vice President, Commercial Innovation (Digital Health, Commercial Digital Lighthouse, Patient Support Solutions and Device Marketing) Anders Dyhr Toft tells MedWatch.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs